Altimmune's (ALT) Market Outperform Rating Reiterated at JMP Securities
JMP Securities reissued their market outperform rating on shares of Altimmune (NASDAQ:ALT – Get Rating) in a report published on Wednesday morning, Benzinga reports. JMP Securities currently has a $26.00 target price on the stock. Other analysts also recently issued reports about the stock. Evercore ISI lifted their price objective on shares of Altimmune from […]